It has been used as a potential target for the treatment of breast cancer.250,251 Therefore, MUC1 aptamers, which have high specific recognition ability with cancer cells overexpressing MUC1, are promising delivery agents for the development of targeted nanoparticles. The gene discussed is MUC1; the disease is cancer.